TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival October 9, 1981